Docosahexaenoic Acid Selectively Suppresses U46619- and PGF<sub>2α</sub>-Induced Contractions in Guinea Pig Tracheal Smooth Muscles

DOI Web Site 被引用文献1件 参考文献17件
  • Obara Keisuke
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Inaba Rikako
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Kawakita Mirai
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • De Dios Regadera Montserrat
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Uetake Tomomi
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Murata Azusa
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Nishioka Nanako
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Kuroki Kota
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Yoshioka Kento
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University
  • Tanaka Yoshio
    Department of Chemical Pharmacology, Faculty of Pharmaceutical Sciences, Toho University

この論文をさがす

抄録

<p>We investigated the potential inhibitory effects of docosahexaenoic acid (DHA) on the contractions of guinea pig tracheal smooth muscles in response to U46619 (a thromboxane A2 (TXA2) mimetic) and prostaglandin F2α (PGF2α) to examine whether this n-3 polyunsaturated fatty acid suppresses prostanoid-induced tracheal contractions. DHA (3 × 10−5 M) significantly suppressed tracheal contractions elicited by lower concentrations of U46619 (10−8 M) and PGF2α (5 × 10−7 M) (vs. control), although it did not suppress the contractions induced by higher concentrations (U46619: 10−7 M; PGF2α: 10−5 M). Supporting these findings, DHA (4 × 10−5 M/6 × 10−5 M) shifted the concentration-response curves for U46619 (10−9–10−6 M) and PGF2α (10−8–10−5 M) to the right. However, the slope of the regression line in the Schild plot of DHA vs. U46619/PGF2α was larger than unity. The tracheal contractions induced by U46619 (10−8 M) and PGF2α (5 × 10−7 M) were significantly suppressed by the prostanoid TP receptor antagonist SQ 29,548 (10−6 M) (vs. ethanol-treated). In contrast, DHA (4 × 10−5 M) did not show significant inhibitory effects on the contractions induced by acetylcholine (10−8–10−4 M), histamine (10−8–10−4 M), and leukotriene D4 (10−11–10−7 M) (vs. ethanol-treated). These findings indicate that DHA selectively suppresses tracheal contractions induced by U46619 and PGF2α. Therefore, DHA may be a useful therapeutic agent against asthma associated with tracheal/bronchial hyper-constriction caused by prostanoids including TXA2 and PGF2α.</p>

収録刊行物

被引用文献 (1)*注記

もっと見る

参考文献 (17)*注記

もっと見る

関連プロジェクト

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ